# Rein Therapeutics, Inc.: Form DEF 14A, filed Jun 8, 2026

- Company: [Rein Therapeutics, Inc.](/companies/rntx.md) (CIK 1420565)
- Form: DEF 14A
- Filed: 2026-06-08
- Accepted by EDGAR: Jun 8, 2026, 09:17 ET
- Period: 2026-07-20
- Accession: 0001193125-26-260809
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1420565/000119312526260809/rntx-20260608.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1420565/000119312526260809/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1420565/000119312526260809/rntx-20260608.htm

Filed Jun 8, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-260809. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.